Data gathered: December 26
AI Stock Analysis - Envista Holdings (NVST)
Analysis generated September 27, 2024. Powered by Chat GPT.
Envista Holdings Corporation is a global leader in dental products and solutions. The company operates through three primary segments: Specialty Products & Technologies, Equipment & Consumables, and Digital Orthodontics & Implant Dentistry Solutions. With a strong brand portfolio and significant investments in technology and innovation, Envista Holdings aims to provide better clinical experiences for patients and improved efficiency for practitioners through their comprehensive range of products and services.
Stock Alerts - Envista Holdings (NVST)
 |
Envista Holdings | December 24 Job postings are down by 20.7% in the last couple of days. |
|
Envista Holdings | December 24 Over the past few months, there has been an upward trend in the business outlook. |
|
Envista Holdings | December 18 Price is down by -5.5% in the last 24h. |
|
Envista Holdings | December 8 AI Score is down by 21.6% in the last couple of days. |
Alternative Data for Envista Holdings
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 63 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 37,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| Patents | 37 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,304 | Sign up | Sign up | Sign up |
| Instagram Followers | 4,067 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 333 | Sign up | Sign up | Sign up |
| Twitter Followers | 59 | Sign up | Sign up | Sign up |
| Twitter Mentions | 20 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 334 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 45 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,003 | Sign up | Sign up | Sign up |
About Envista Holdings
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
| Price | $19.33 |
| Target Price | Sign up |
| Volume | 139,280 |
| Market Cap | $3.26B |
| Year Range | $15.3 - $22.33 |
| Dividend Yield | 0% |
| PE Ratio | 22.44 |
| Analyst Rating | 27% buy |
| Industry | Medical & Dental Instruments |
In the news
 |
Tidal Investments LLC Sells 15,706 Shares of Envista Holdings Co. (NYSE:NVST)December 24 - ETF Daily News |
|
M&T Bank Corp Purchases 4,787 Shares of Envista Holdings Co. (NYSE:NVST)December 19 - ETF Daily News |
|
Rockefeller Capital Management L.P. Has $238,000 Stock Position in Envista Holdings Co. (NYSE:NVST)December 11 - ETF Daily News |
|
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 3,199 Shares of Envista Holdings Co. (NYSE:NVST)December 10 - ETF Daily News |
|
Head to Head Contrast: Envista (NYSE:NVST) vs. Lancer Orthodontics (OTCMKTS:LANZ)December 7 - ETF Daily News |
|
Envista Holdings Co. (NYSE:NVST) Receives $20.65 Average PT from BrokeragesDecember 7 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 601M | 555M | 317M | 8.2M | 40M | 0.120 |
| Q2 '24 | 633M | 1.78B | 327M | -1.15B | -1.13B | 0.110 |
| Q1 '24 | 611M | 575M | 356M | 24M | 71M | 0.260 |
| Q4 '23 | 690M | 950M | 336M | -217M | -78M | 0.290 |
| Q3 '23 | 616M | 526M | 363M | 22M | 75M | 0.430 |
Insider Transactions View All
| Keel Paul A filed to buy 402,605 shares at $16.9. August 14 '24 |
| Hammes Eric D. filed to buy 24,532 shares at $16.3. August 13 '24 |
| Conley Eric filed to buy 47,374 shares at $22.9. November 20 '23 |
| Conley Eric filed to buy 47,376 shares at $22.9. November 20 '23 |
| Conley Eric filed to buy 47,373 shares at $22.9. November 20 '23 |
Similar companies
Read more about Envista Holdings (NVST) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Envista Holdings?
The Market Cap of Envista Holdings is $3.26B.
What is Envista Holdings' PE Ratio?
As of today, Envista Holdings' PE (Price to Earnings) ratio is 22.44.
What is the current stock price of Envista Holdings?
Currently, the price of one share of Envista Holdings stock is $19.33.
How can I analyze the NVST stock price chart for investment decisions?
The NVST stock price chart above provides a comprehensive visual representation of Envista Holdings' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Envista Holdings shares. Our platform offers an up-to-date NVST stock price chart, along with technical data analysis and alternative data insights.
Does NVST offer dividends to its shareholders?
As of our latest update, Envista Holdings (NVST) does not offer dividends to its shareholders. Investors interested in Envista Holdings should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Envista Holdings?
Some of the similar stocks of Envista Holdings are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.